The first stop for professional medicines advice

Canakinumab

Published
Topics: CanakinumabCancersMusculo-skeletal disorders · New MedicinesNHS England commissioned new medicinesPatent expiriesPre-registration new medicines (UK/EU)Safety in BreastfeedingStability outside the fridge ·
Contents
  1. dm+d
  2. Refrigerated Storage
    1. Ilaris · Novartis Pharmaceuticals
  3. Lactation Safety Information
    1. For inherited auto-inflammatory disorders
    2. For acute gout

dm+d

16591711000001109

Refrigerated Storage

IlarisNovartis Pharmaceuticals

Novartis Pharmaceuticals
Ilaris
150 mg/mL solution for injection

Contact Novartis Pharmaceuticals in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details.

26 January 2022
London MI Service

Lactation Safety Information

For inherited auto-inflammatory disorders

For inherited auto-inflammatory disorders
Caution
-
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties. However, long half-life increases risk of accumulation in breastfed infants
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
Safety in Lactation: Other immunomodulating drugs
17 September 2020
Bibliography

For acute gout

For acute gout
Caution
NSAIDs
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties. However, long half-life increases risk of accumulation in breastfed infants
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
Safety in Lactation: Gout and cytotoxic-induced hyperuricaemia
17 September 2020
Bibliography